DSSTox_CID_3270

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

104 API Suppliers, 55 USDMF, 39 CEP/COS, 12 JDMF, 29 EU WC, 95 KDMF, 39 NDC API, 39 Listed Suppliers

DEVELOPMENTS

21 Drug(s) in Development

21 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Formulations

1512 Dossiers, 411 FDA Orange Book, 375 Europe, 122 Canada, 71 Australia, 114 South Africa, 419 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE
TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE
TABLET;ORAL - 2.5MG;1GM
TABLET;ORAL - 2.5MG;500MG
TABLET;ORAL - 2.5MG;850MG
TABLET;ORAL - EQ 12.5MG BASE;1GM
TABLET;ORAL - EQ 12.5MG BASE;500MG
TABLET;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM
TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG
TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM
TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG
TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION, EXTENDED RELEASE;ORAL - 500MG/5ML
TABLET, EXTENDED RELEASE;ORAL - 1GM
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - 500MG/5ML
TABLET, EXTENDED RELEASE;ORAL - 1GM
TABLET, EXTENDED RELEASE;ORAL - 500MG
TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 850MG;EQ 15MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE
TABLET;ORAL - 1GM;EQ 50MG BASE
TABLET;ORAL - 500MG;EQ 50MG BASE
TABLET;ORAL - 500MG;1MG
TABLET;ORAL - 500MG;2MG

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 38 BASF, 35 Roquette, 27 Corel Pharma Chem, 22 SPI Pharma, 22 Microlex e.U, 14 Gangwal Healthcare, 14 Seppic, 13 Gangwal Chemicals, 12 Nanjing Well Pharmaceutical, 12 Actylis, 12 Sigachi Industries, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 Boai NKY Pharmaceuticals Ltd, 8 Rochem International Inc, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Prachin Chemical, 5 DKSH, 5 Kima Chemical, 5 Lubrizol Life Science Health, 5 Ingredion Pharma Solutions, 5 Pharmatrans-Sanaq, 4 Alcedo Pharmachem, 4 The Dow Chemical Company, 4 Ulanqab Kema New Material, 4 Evonik, 4 Vasa Pharmachem, 3 Pharm-RX Chemical, 3 Jai Radhe Sales, 3 Aeon Procare, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Zhejiang Huakang Pharmaceutical, 2 Clariant, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Minakem, 2 Seqens, 2 Finar, 2 Vertellus, 2 Pfanstiehl, 1 Chynops Pharma, 1 ACG Worldwide, 1 Avesta Pharma, 1 Qualicaps, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Bioplus Life Sciences, 1 Doshion Polyscience, 1 Huzhou Sunflower Pharmaceutical, 1 NEWEDGE Overseas

EXCIPIENTS BY APPLICATIONS

115 Fillers, Diluents & Binders, 62 Coating Systems & Additives, 58 Controlled & Modified Release, 58 Direct Compression, 50 Disintegrants & Superdisintegrants, 44 Thickeners and Stabilizers, 44 Solubilizers, 40 Granulation, 36 Film Formers & Plasticizers, 36 Taste Masking, 32 Topical, 31 Lubricants & Glidants, 28 Parenteral, 24 Chewable & Orodispersible Aids, 18 Co-Processed Excipients, 12 API Stability Enhancers, 12 Emulsifying Agents, 7 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin